2024年4月8日 · Singulair is used to prevent asthma attacks in adults and children as young as 12 months old. Singulair is also used to prevent exercise-induced bronchoconstriction (narrowing of the air passages in the lungs) in adults and children who are at least 6 years old.

2024年1月17日 · Singulair, or montelukast, is a prescription medication that helps prevent asthma attacks in people aged 12 months and over. Singulair can also provide relief for seasonal, indoor, and outdoor...

2023年3月22日 · Montelukast is an orally dosed drug (available as a film-coated tablet, chewable tablet, or oral granules) that is FDA-approved for treating chronic asthma and prophylaxis and the prevention of exercise-induced bronchoconstriction. It is also approved to relieve seasonal and perennial allergic rhinitis symptoms.

2024年10月15日 · Singulair is an oral prescription medication that can prevent or reduce acute asthma attacks in adults and children over 12 months old. It’s available in pill form or in granules. Singulair can...

2023年10月4日 · Montelukast helps to reduce inflammation and may be used to prevent asthma attacks in adults and children at least 2 years old.

Montelukast, sold under the brand name Singulair among others, is a medication used in the maintenance treatment of asthma. [6] It is generally less preferred for this use than inhaled corticosteroids. [6] It is not useful for acute asthma attacks. [6] Other uses include allergic rhinitis and hives of long duration. [6]

2024年6月13日 · How does montelukast work (mechanism of action)? Montelukast helps improve asthma symptoms by blocking substances in the body called leukotrienes that cause inflammation and swelling.

2020年2月23日 · Mechanism of Action. Selective leukotriene receptor antagonist that inhibits the cysteinyl leukotriene receptor.

Montelukast is an orally active compound that binds with high affinity and selectivity to the CysLT1 receptor (in preference to other pharmacologically important airway receptors, such as the...

2025年1月3日 · The efficacy of SINGULAIR for the chronic treatment of asthma in adults and adolescents 15 years of age and older was demonstrated in two (U.S. and Multinational) similarly designed, randomized, 12-week, double-blind, placebo-controlled trials in 1576 patients (795 treated with SINGULAIR, 530 treated with placebo, and 251 treated with active ...

SINGULAIR® (MONTELUKAST SODIUM) TABLETS, CHEWABLE TABLETS, AND ORAL GRANULES DESCRIPTION Montelukast sodium, the active ingredient in SINGULAIR*, is a selective and orally active leukotriene...

How does montelukast work (mechanism of action)? Montelukast helps improve asthma symptoms by blocking substances in the body called leukotrienes that cause inflammation and swelling. How is...

Mechanism of action. Levothyroxine is a synthetically prepared levo-isomer of the thyroid hormone thyroxine (T 4, a tetra-iodinated tyrosine derivative) that acts as a replacement in deficiency syndromes such as hypothyroidism.

Therapeutic Class: SINGULAIR (montelukast sodium) is a selective and orally active leukotriene receptor antagonist that specifically inhibits the cysteinyl leukotriene CysLT 1 receptor. Pharmacology: Mechanism of Action: The cysteinyl leukotrienes (LTC 4 , LTD 4 , LTE 4 ), are potent inflammatory eicosanoids released from various cells ...

2024年10月21日 · SINGULAIR is a leukotriene receptor antagonist indicated for: Prophylaxis and chronic treatment of asthma in patients 12 months of age and older (1.1). Acute prevention of exercise-induced bronchoconstriction (EIB) in patients 6 years of age and older (1.2).

Montelukast is used to prevent wheezing, difficulty breathing, chest tightness, and coughing caused by asthma in adults and children 12 months of age and older. Montelukast is also used to prevent bronchospasm (breathing difficulties) during …

2012年2月16日 · 12.1 Mechanism of Action. The cysteinyl leukotrienes (LTC 4, LTD 4, LTE 4) are products of arachidonic acid metabolism and are released from various cells, including mast cells and eosinophils. These eicosanoids bind to cysteinyl leukotriene (CysLT) receptors.

Montelukast is used to treat or prevent asthma, to treat seasonal and year-round allergies, and to prevent difficulty breathing during exercise. The brand name for montelukast is Singulair ®. Montelukast comes in tablets, chewable tablets, and granules.

for the prophylaxis and chronic treatment of asthma in adults and pediatric patients 6 years of age and older. It is NOT indicated for use in the reversal of bronchospasm in acute asthma attacks. Undergoes extensive metabolism by different Cyt P450 isoforms including CYP3A4, 2C8, …

2023年5月15日 · Singulair (montelukast) is a leukotriene receptor antagonist drug used in the treatment of asthma and allergic rhinitis. Singulair is also indicated for prevention of exercise-induced narrowing of the airways. What Are Side Effects of Singulair? Singulair may cause serious side effects including: